glp-1 pipeline news Visible Alpha drug monitor – The emerging GLP-1 Pipeline Update: November 2024

The blockbuster weight loss medications that have transformed conversations about obesity and metabolic healthsemaglutide (Ozempic and Wegovy), tirzepatide (Zepbound or Mounjaro), and retatrutide (a newcomer on the block thats not yet FDA approved but highly anticipated for approval next year)are all peptide-based drugs

Together with rich moisturizers it makes skin irresistibly silky and soft to touch

A clinical trial investigated the effect of 8-week metformin treatment on aging individuals with mild cognitive impairment (MCI) or early AD, and the results revealed that metformin is associated with improved executive function, companied by improvement in learning/memory and attention [27]

However, patients tend to tolerate these side effects because of the significant weight loss benefits they experience - something metformin does not offer

Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years